verapamil has been researched along with fendiline in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (48.48) | 18.7374 |
| 1990's | 9 (27.27) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 3 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Gatsura, SV; Gukasov, VM | 1 |
| Scultéty, S; Tamáskovits, E | 1 |
| Röttgers, U; Scheid, W; Traut, H; Weber, J | 1 |
| Katsenovich, RA; Kostko, SZ; Shil'kurt, BL; Stepanova, TG; Tkachenko, BI | 1 |
| Fabrègues, E; John, GW; Kamal, M; Massingham, R | 1 |
| Hála, O; Papp, JG; Szekeres, L | 1 |
| Burtsev, EM; Savkov, VS | 1 |
| Robak, J; Shridi, F | 1 |
| Bettini, V; Catozzo, C; Martino, R; Mayellaro, F; Munari, L; Tegazzin, V; Ton, P | 1 |
| Shcherbakov, AB | 1 |
| Cartheuser, CF | 1 |
| Guseva, NG; Mach, ES; Shcherbakov, AB | 1 |
| Duniec, Z; Robak, J | 1 |
| Katsenovich, RA; Kostko, SZ | 1 |
| Hütter, JF; Piper, HM; Spieckermann, PG | 1 |
| Fossati, C; Guistiniani, S | 1 |
| Baker, JE; Hearse, DJ | 1 |
| Becker, HJ; Dowinsky, S; Hopf, R; Kaltenbach, M; Kober, G | 1 |
| Candau, LA; Carvalho, CR; Lavall, MA; Pereira, LS | 1 |
| Csik, V; Szekeres, L; Udvary, E | 1 |
| Hochrein, H; Lehmann, HU | 1 |
| Harmony, JA; Jackson, RJ; Ranganathan, S | 1 |
| Meera, P; Prakash, P; Tripathi, O | 1 |
| Klein, G; Nawrath, H; Rupp, J; Shainberg, A; Wegener, JW | 1 |
| Hamar, J; Perner, F; Szende, B; Toronyi, E | 1 |
| Chan, R; Cheng, J; Chou, K; Chung Lee, K; Jan, C; Lo, Y; Tang, K; Tseng, L; Wang, J | 1 |
| Chang, HT; Cheng, JS; Chou, KJ; Jan, CR; Lee, KC; Lo, YK; Tang, KY; Wang, JL | 1 |
| Toronyi, E | 1 |
5 review(s) available for verapamil and fendiline
| Article | Year |
|---|---|
Enhancement of the mutagenicity of anticancer drugs by the calcium antagonists verapamil and fendiline.
Topics: Animals; Antineoplastic Agents; Drug Synergism; Fendiline; Humans; Mutagenicity Tests; Mutagens; Verapamil | 1991 |
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendiline; Gastrointestinal Diseases; Humans; Lidoflazine; Nervous System Diseases; Nifedipine; Perhexiline; Prenylamine; Verapamil | 1984 |
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; Exercise Test; Fendiline; Humans; Nicardipine; Nifedipine; Perhexiline; Prenylamine; Propafenone; Propiophenones; Verapamil | 1982 |
[Indications for use of calcium antagonists].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Coronary Disease; Female; Fendiline; Humans; Hyperinsulinism; Hypertension; Nifedipine; Obstetric Labor, Premature; Paraganglioma; Perhexiline; Pregnancy; Prenylamine; Vasodilator Agents; Verapamil | 1980 |
[Role of apoptosis in the kidney after reperfusion].
Topics: Animals; Apoptosis; Bepridil; Calcium Channel Blockers; Disease Models, Animal; Fendiline; Humans; Kidney Transplantation; Kidney Tubules; Monoamine Oxidase Inhibitors; Nifedipine; Reperfusion Injury; Selegiline; Vasodilator Agents; Verapamil | 2008 |
2 trial(s) available for verapamil and fendiline
| Article | Year |
|---|---|
[Treatment of Raynaud's syndrome with calcium entry blockers].
Topics: Adolescent; Adult; Calcium Channel Blockers; Clinical Trials as Topic; Female; Fendiline; Humans; Male; Middle Aged; Nifedipine; Random Allocation; Raynaud Disease; Regional Blood Flow; Skin Temperature; Verapamil | 1987 |
[Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
Topics: Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Female; Fendiline; Humans; Male; Phenethylamines; Verapamil | 1982 |
26 other study(ies) available for verapamil and fendiline
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[The effect of calcium antagonists on blood deoxygenation processes].
Topics: Animals; Blood; Calcium Channel Blockers; Dose-Response Relationship, Drug; Fendiline; Nifedipine; Oxygen; Polarography; Rats; Verapamil | 1992 |
Effect of Ca2+ antagonists on isolated rabbit detrusor muscle.
Topics: Animals; Calcium; Calcium Channel Blockers; Cinnarizine; Electric Stimulation; Female; Fendiline; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Prenylamine; Rabbits; Verapamil | 1991 |
[Change in inotropic and chronotropic function of the heart and resistance of the coronary vessels during combined use of Ca2+ antagonists].
Topics: Animals; Calcium Channel Blockers; Cats; Coronary Vessels; Drug Combinations; Fendiline; Heart; In Vitro Techniques; Myocardial Contraction; Nifedipine; Oxygen Consumption; Vascular Resistance; Verapamil | 1991 |
Caffeine-induced contractions in rabbit isolated renal artery are differentially inhibited by calcium antagonists.
Topics: Animals; Bepridil; Caffeine; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Flunarizine; Kinetics; Lidoflazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Renal Artery; Verapamil | 1991 |
Mechanical activity of the ischaemic myocardium as affected by verapamil and fendiline.
Topics: Animals; Coronary Disease; Electric Stimulation; Fendiline; Heart; In Vitro Techniques; Myocardial Contraction; Phenethylamines; Rabbits; Verapamil | 1990 |
[Calcium antagonists (finoptin and senzit) in the treatment of cerebrovascular disorders].
Topics: Adult; Age Factors; Arteriosclerosis; Cerebrovascular Disorders; Drug Evaluation; Fendiline; Humans; Hypertension; Middle Aged; Phenethylamines; Verapamil | 1989 |
The influence of calcium channel blockers on superoxide anions.
Topics: Animals; Anions; Calcium Channel Blockers; Diltiazem; Fendiline; Free Radicals; In Vitro Techniques; Microsomes, Liver; Nifedipine; Oxidation-Reduction; Rats; Superoxides; Verapamil; Xanthine Oxidase | 1988 |
[Changes in acetylcholine contractions induced by carnitine in coronary vessels isolated "in vitro"].
Topics: Acetylcholine; Animals; Atropine; Calcium; Carnitine; Cattle; Coronary Vessels; Fendiline; In Vitro Techniques; Kinetics; Muscle Contraction; Pyrrolidines; Receptors, Muscarinic; Verapamil | 1985 |
[Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
Topics: Blood Circulation; Calcium Channel Blockers; Connective Tissue Diseases; Drug Evaluation; Fendiline; Humans; Nifedipine; Random Allocation; Raynaud Disease; Skin Temperature; Time Factors; Verapamil | 1988 |
Slow channel inhibitor effects on brain function: tolerance to severe hypoxia in the rat.
Topics: Animals; Bencyclane; Bepridil; Brain; Calcium Channel Blockers; Cinnarizine; Diltiazem; Electroencephalography; Fendiline; Flunarizine; Gallopamil; Heart Rate; Hypoxia; Nimodipine; Prenylamine; Pyrrolidines; Rats; Rats, Inbred Strains; Respiration; Verapamil | 1988 |
Membrane activity, antioxidant, antiaggregatory and antihemolytic properties of four calcium channel blockers.
Topics: Animals; Antioxidants; Blood Platelets; Calcium Channel Blockers; Cell Membrane; Diltiazem; Erythrocytes; Fendiline; Hemolysis; In Vitro Techniques; Nifedipine; Platelet Aggregation; Rabbits; Verapamil | 1986 |
[Various aspects of the effects of beta adrenergic receptor blockaders, stimulants and calcium antagonists on the cardiovascular system].
Topics: Adult; Animals; Calcium Channel Blockers; Cardiovascular System; Cats; Coronary Disease; Coronary Vessels; Drug Interactions; Drug Therapy, Combination; Fendiline; Humans; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Nonachlazine; Phenothiazines; Propranolol; Verapamil | 1985 |
Temperature dependence of calcium antagonist action.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Kinetics; Myocardial Contraction; Myocardium; Nifedipine; Rats; Temperature; Verapamil | 1985 |
Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs.
Topics: Animals; Butylamines; Calcium; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Gallopamil; In Vitro Techniques; Ion Channels; Male; Myocardium; Nifedipine; Prenylamine; Rats; Verapamil | 1983 |
Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort.
Topics: Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Disease; Dogs; Electrocardiography; Female; Fendiline; Hemodynamics; Lactates; Lactic Acid; Male; Myocardium; Oxygen Consumption; Phenethylamines; Vascular Resistance; Verapamil | 1983 |
Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblasts.
Topics: Benzazepines; Calcium Channel Blockers; Dibucaine; Diltiazem; Fendiline; Fibroblasts; Gallopamil; Humans; Kinetics; Lipoproteins, LDL; Nifedipine; Phenethylamines; Prenylamine; Pyridines; Skin; Trifluoperazine; Verapamil | 1982 |
Effects of calcium channel blockers on spontaneous electrical activity of freshly isolated three-day-old embryonic chick ventricle.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Chick Embryo; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Heart Ventricles; In Vitro Techniques; Isoproterenol; Nifedipine; Regression Analysis; Tetrodotoxin; Ventricular Function; Verapamil | 1996 |
Open state block by fendiline of L-type Ca++ channels in ventricular myocytes from rat heart.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Female; Fendiline; Heart; Male; Rats; Rats, Sprague-Dawley; Verapamil | 1998 |
Prevention of apoptosis reperfusion renal injury by calcium channel blockers.
Topics: Animals; Apoptosis; Bepridil; Calcium Channel Blockers; Fendiline; Kidney; Kidney Tubules; Male; Nifedipine; Rats; Rats, Wistar; Reperfusion Injury; Severity of Illness Index; Time Factors; Verapamil | 1999 |
The anti-anginal drug fendiline increases intracellular Ca(2+) levels in MG63 human osteosarcoma cells.
Topics: Calcium; Calcium Channel Blockers; Carcinogens; Chelating Agents; Fendiline; Fura-2; Humans; Osteosarcoma; Thapsigargin; Tumor Cells, Cultured; Verapamil | 2001 |
Fendiline-Induced Ca2+ movement in A10 smooth muscle cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Fendiline; Fluorescent Dyes; Fura-2; Lanthanum; Muscle, Smooth, Vascular; Nifedipine; Thapsigargin; Vasodilator Agents; Verapamil | 2001 |